CORC  > 华南理工大学
Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia (CPCI-S收录)
Zhou, Guangbiao[1]; Hu, Zheng[1]; Pan, Xiaofen[1]; Liu, Jinglei[1]; Ma, Liyuan[2]; Liu, Xiaoli[3]; Meng, Fanyi[3]; Li, Juan[4]; Chen, Zhu[2]; Chen, Saijuan
会议名称BLOOD
URL标识查看原文
内容类型会议论文
URI标识http://www.corc.org.cn/handle/1471x/2101489
专题华南理工大学
作者单位1.[1]Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab Mol Target Based Therapy Canc, Guangzhou, Guangdong, Peoples R China
2.[2]Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol, Shanghai 200030, Peoples R China
3.[3]Nanfang Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
4.[4]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Zhou, Guangbiao[1],Hu, Zheng[1],Pan, Xiaofen[1],等. Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia (CPCI-S收录)[C]. 见:BLOOD.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace